Stocks · Korea
206640
KOSDAQ
Boditech Med
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
PER9.10x
PBR0.92x
EPS1,091 KRW
BPS10,787 KRW
ROE10.24%
Dividend yield1.51%
DPS150 KRW
Payout ratio13.75%
Returns and 52-week range
1W+5.08%
1M+1.22%
3M-8.82%
6M-11.73%
1Y-32.49%
YTD-25.23%
52W high15,000원
52W low9,250원
From 52W high-33.80%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 1,181억 | 247억 | 253억 | 20.9% |
| 2023 | 1,342억 | 285억 | 267억 | 21.2% |
| 2024 | 1,382억 | 262억 | 272억 | 18.9% |
| 2025 | 1,621억 | 289억 | 239억 | 17.9% |
| Quarterly | ||||
| 2024 4Q | 312억 | 22억 | 48억 | 6.9% |
| 2025 1Q | 391억 | 81억 | 73억 | 20.7% |
| 2025 2Q | 415억 | 92억 | 75억 | 22.2% |
| 2025 3Q | 399억 | 66억 | 78억 | 16.5% |
| 2025 4Q | 416억 | 51억 | 14억 | 12.2% |
| 2026 1Q | 428억 | 68억 | 95억 | 15.9% |
Company
Address: 강원도 춘천시 동내면 거두단지1길 43 -
Peers in the same sector
Recent filings
- 2026-09-22주요사항보고서(자기주식취득신탁계약해지결정) Major
- 2026-08-14반기보고서 (2026.06)
- 2026-07-27주요사항보고서(자기주식취득신탁계약체결결정) Major
- 2026-07-27[기재정정]사업보고서 (2025.12)
- 2026-05-15분기보고서 (2026.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.